The enzymes in COVID-19: A review

Biochimie. 2022 Jun:197:38-48. doi: 10.1016/j.biochi.2022.01.015. Epub 2022 Jan 26.

Abstract

COVID-19 brought a scientific revolution since its emergence in Wuhan, China, in December 2019. Initially, the SARS-CoV-2 virus came to attention through its effects on the respiratory system. However, its actions in many other organs also have been discovered almost daily. As enzymes are indispensable to uncountable biochemical reactions in the human body, it is not surprising that some enzymes are of relevance to COVID-19 pathophysiology. Past evidence from SARS-CoV and MERS-CoV outbreaks provided hints about the role of enzymes in SARS-CoV-2 infection. In this setting, ACE-2 is an enzyme of great importance since it is the cell entry receptor for SARS-CoV-2. Clinical data elucidate patterns of enzymatic alterations in COVID-19, which could be associated with organ damage, prognosis, and clinical complications. Further, viral mutations can create new disease behaviors, and these effects are related to the activity of enzymes. This review will discuss the main enzymes related to COVID-19, summarizing the findings on their role in viral entry mechanism, the consequences of their dysregulation, and the effects of SARS-CoV-2 mutations on them.

Keywords: ACE-2; Coronavirus; S protein; SARS-CoV-2.

Publication types

  • Review

MeSH terms

  • COVID-19*
  • China
  • Humans
  • Middle East Respiratory Syndrome Coronavirus*
  • SARS-CoV-2